SARS-CoV-2 cell entry beyond the ACE2 receptor.

Published in: Molecular biology reports (2022)

The high rate of infectivity of SARS-CoV-2 may be due to its ability to enter the host cell through a group of cell surface receptors. These receptors are potential targets to develop novel therapeutic agents for SARS-CoV-2.

Keyphrases

sars cov
respiratory syndrome coronavirus
cell surface
single cell
cell therapy
coronavirus disease
risk assessment
bone marrow